Co-Diagnostics (CODX) Competitors $0.44 +0.01 (+1.84%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$0.44 0.00 (-0.21%) As of 09/19/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CODX vs. SRTS, MDAI, GUTS, APT, WOK, MLSS, NEPH, ZYXI, NMTC, and PSTVShould you be buying Co-Diagnostics stock or one of its competitors? The main competitors of Co-Diagnostics include Sensus Healthcare (SRTS), Spectral AI (MDAI), Fractyl Health (GUTS), Alpha Pro Tech (APT), WORK Medical Technology Group (WOK), Milestone Scientific (MLSS), Nephros (NEPH), Zynex (ZYXI), NeuroOne Medical Technologies (NMTC), and Plus Therapeutics (PSTV). These companies are all part of the "medical equipment" industry. Co-Diagnostics vs. Its Competitors Sensus Healthcare Spectral AI Fractyl Health Alpha Pro Tech WORK Medical Technology Group Milestone Scientific Nephros Zynex NeuroOne Medical Technologies Plus Therapeutics Sensus Healthcare (NASDAQ:SRTS) and Co-Diagnostics (NASDAQ:CODX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation. Does the media prefer SRTS or CODX? In the previous week, Co-Diagnostics had 3 more articles in the media than Sensus Healthcare. MarketBeat recorded 6 mentions for Co-Diagnostics and 3 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 0.60 beat Co-Diagnostics' score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sensus Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Co-Diagnostics 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, SRTS or CODX? Sensus Healthcare has a beta of 1.41, meaning that its stock price is 41% more volatile than the S&P 500. Comparatively, Co-Diagnostics has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500. Which has preferable earnings & valuation, SRTS or CODX? Sensus Healthcare has higher revenue and earnings than Co-Diagnostics. Sensus Healthcare is trading at a lower price-to-earnings ratio than Co-Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSensus Healthcare$41.81M1.22$6.65M-$0.06-51.83Co-Diagnostics$3.91M4.31-$37.64M-$1.15-0.38 Do institutionals & insiders believe in SRTS or CODX? 25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 15.0% of Co-Diagnostics shares are owned by institutional investors. 8.9% of Sensus Healthcare shares are owned by insiders. Comparatively, 8.4% of Co-Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts recommend SRTS or CODX? Sensus Healthcare presently has a consensus target price of $8.00, indicating a potential upside of 157.23%. Co-Diagnostics has a consensus target price of $5.50, indicating a potential upside of 1,155.99%. Given Co-Diagnostics' higher possible upside, analysts plainly believe Co-Diagnostics is more favorable than Sensus Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Co-Diagnostics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00 Is SRTS or CODX more profitable? Sensus Healthcare has a net margin of -2.26% compared to Co-Diagnostics' net margin of -3,588.33%. Sensus Healthcare's return on equity of -1.58% beat Co-Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Sensus Healthcare-2.26% -1.58% -1.41% Co-Diagnostics -3,588.33%-69.49%-60.49% SummarySensus Healthcare beats Co-Diagnostics on 11 of the 16 factors compared between the two stocks. Get Co-Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CODX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CODX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CODX vs. The Competition Export to ExcelMetricCo-DiagnosticsMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.57M$7.65B$5.79B$10.40BDividend YieldN/A2.82%5.63%4.60%P/E Ratio-0.3878.6576.4826.76Price / Sales4.3138.37531.72124.23Price / CashN/A25.4237.9261.55Price / Book0.267.7613.726.40Net Income-$37.64M$241.92M$3.29B$271.62M7 Day Performance28.38%24.28%2.66%3.46%1 Month Performance55.39%3.21%6.02%9.87%1 Year Performance-66.05%5.41%80.02%28.45% Co-Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CODXCo-Diagnostics3.7813 of 5 stars$0.44+1.8%$5.50+1,156.0%-65.5%$16.57M$3.91M-0.38100News CoverageAnalyst ForecastGap UpSRTSSensus Healthcare2.7084 of 5 stars$3.15-0.9%$8.00+154.0%-47.4%$52.28M$37.56M-52.5040MDAISpectral AI2.352 of 5 stars$1.99+2.6%$3.50+75.9%+123.1%$51.86M$27.55M-2.8883News CoverageGap UpGUTSFractyl Health2.7678 of 5 stars$0.98-3.7%$7.15+628.1%-63.7%$51.30M$17K-0.48102Analyst RevisionHigh Trading VolumeAPTAlpha Pro Tech2.6795 of 5 stars$4.84-1.0%N/A-19.3%$50.69M$58.56M13.08120Positive NewsWOKWORK Medical Technology GroupN/A$0.80flatN/A-81.8%$45.60M$11.51M0.00226High Trading VolumeMLSSMilestone Scientific2.5589 of 5 stars$0.58-1.6%$1.25+115.4%-43.2%$45.59M$9.08M-8.2930Negative NewsNEPHNephros3.2378 of 5 stars$4.36+2.3%$5.50+26.1%+131.6%$45.16M$14.16M36.3330High Trading VolumeZYXIZynex1.869 of 5 stars$1.48flat$4.90+231.1%-81.4%$44.84M$192.35M-1.57770NMTCNeuroOne Medical Technologies2.0958 of 5 stars$0.88-1.0%$2.23+152.8%-0.5%$44.46M$6.63M-5.8720Gap UpPSTVPlus Therapeutics3.2488 of 5 stars$0.41-7.7%$7.88+1,807.2%-74.0%$44.40MN/A-0.1820News CoverageAnalyst ForecastShort Interest ↑ Related Companies and Tools Related Companies SRTS Competitors MDAI Competitors GUTS Competitors APT Competitors WOK Competitors MLSS Competitors NEPH Competitors ZYXI Competitors NMTC Competitors PSTV Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CODX) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Co-Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Co-Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CODX Stock Alerts